Israeli lipids ingredients specialist Enzymotec has acquired an American supplement developer in a move to revitalize its stumbling medical foods subsidiary that has run into regulatory difficulties in the United States.
from NutraIngredients RSS http://ift.tt/2erGi1q
via IFTTT